Oct 20, 2021
There are 2,600 gen and cell therapy
clinical trials taking place this year. In the US alone, this could
translate up to 20 new therapy approvals in 2022, which presents a
clear opportunity to make more life-saving therapies available to a
greater number of individuals. As the evolution of medicine
continues, the future looks promising for advancements in cell and
gene therapy.
In this podcast, Adlai Goldberg, Global
Digital, Social and Commercial Innovation Life Sciences Leader for
EY, talks to Tamie Joeckel – ICON’s Cell and Gene Therapy Global
Business Lead, as they discuss the use of technology in medicine
and what makes an increase in the volume of clinical trials,
including cgt clinical trials, and an acceleration of the clinical
trial process significant.